导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 27.15% | 163/1050 |
| 近一周 | 0.64% | 209/1104 |
| 近一月 | -4.78% | 750/1103 |
| 近一季 | -13.64% | 825/1092 |
| 近半年 | 20.37% | 162/1070 |
| 近一年 | 37.50% | 136/1018 |
| 近两年 | 199.60% | 65/926 |
| 近三年 | 161.55% | 56/834 |
| 成立以来 | 350.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.26% 770/1070 |
65.33% 158/1101 |
- - |
- - |
| 2025 | 66.28% 77/1065 |
4.67% 430/1014 |
4.19% 350/1038 |
55.52% 54/1050 |
-1.95% 553/1065 |
| 2024 | 30.16% 21/1011 |
1.50% 232/960 |
-0.12% 316/983 |
11.22% 527/991 |
15.45% 30/1011 |
| 2023 | -11.31% 376/952 |
7.93% 174/880 |
-0.42% 212/895 |
-11.15% 635/915 |
-7.11% 687/952 |
| 2022 | -35.87% 711/867 |
-22.16% 645/773 |
7.73% 361/806 |
-16.68% 664/845 |
-8.21% 739/867 |
| 2021 | 24.75% 116/740 |
-12.48% 533/580 |
33.10% 36/659 |
-3.21% 296/704 |
10.65% 67/740 |
| 2020 | 64.15% 170/554 |
2.22% 109/419 |
35.83% 61/466 |
5.51% 356/517 |
12.06% 292/554 |
| 2019 | 80.63% 8/410 |
29.14% 422/1146 |
-4.48% 673/1228 |
23.96% 6/390 |
18.13% 23/410 |
| 2018 | - - |
- - |
- - |
- - |
-5.35% 60/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈人工智能股票A VS. 东吴新产业精选股票A(580008) |